AMP SLE Phase II PBMC CITE-seq - version 3

Accelerating Medicines Partnership RA/SLE Network

DOI: 10.7303/syn75065673.3
Published: 2026
Container: Not recorded
Publisher: Synapse
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7303/syn75065673.3,
  title = {AMP SLE Phase II PBMC CITE-seq - version 3},
  author = {Accelerating Medicines Partnership RA/SLE Network},
  year = {2026},
  doi = {10.7303/syn75065673.3},
  url = {https://doi.org/10.7303/syn75065673.3}
}

RIS

TY  - JOUR
TI  - AMP SLE Phase II PBMC CITE-seq - version 3
AU  - Accelerating Medicines Partnership RA/SLE Network
PY  - 2026
DO  - 10.7303/syn75065673.3
UR  - https://doi.org/10.7303/syn75065673.3
ER  -

APA

Network, A. M. P. R. (2026). AMP SLE Phase II PBMC CITE-seq - version 3. https://doi.org/10.7303/syn75065673.3

Source records

datacite · retrieved 2026-09-25T04:30:46.178Z